Honeywell Aerospace Inc

Honeywell Aerospace reported third-quarter organic sales growth of 2.4% to $4.6 billion. Third-quarter adjusted EBIT was $1.2 billion, up 4% versus pro forma standalone adjusted EBIT last year, and adjusted EPS was $2.21. Free cash flow was $0.5 billion. Management said adjusted EBIT benefited from about $50 million of net IEEPA tariff refunds, adding more than 100 basis points to margin. Backlog increased 12% year over year to more than $19 billion, trailing 12-month orders rose 9%, and book-to-bill was 1.1. For 2026, the company kept organic growth guidance at 4% to 5%, narrowed adjusted EBIT guidance around a $4.4 billion midpoint, raised adjusted EPS guidance to $7.85 to $8, and lifted second-half free cash flow guidance to $1.2 billion to $1.4 billion. Management also said fourth-quarter organic sales should be modestly below the full-year range and that fourth-quarter margin should be more similar to the first half because no IEEPA tariff refunds are expected.

Jim Currier’s message was that demand is strong, but the company’s growth is being held back by supply rather than customer appetite. He repeatedly emphasized that fixing supplier bottlenecks, expanding multi-sourcing, and increasing in-sourcing are the main levers to unlock faster sales growth in 2027 and beyond. His tone was confident and execution-focused, with frequent references to backlog, customer wins, and the company’s ability to create value through its operating system and capital allocation.

Josh Jepsen framed the quarter as better than expected, with $4.6 billion of sales, $1.2 billion of adjusted EBIT, $2.21 of adjusted EPS, and $0.5 billion of free cash flow. He said margins benefited from about $50 million of tariff refunds in the quarter, but fourth-quarter margin will step down because those refunds are not expected to recur; he also pointed to mix headwinds from more commercial OE and domestic defense volume. On capital allocation, he highlighted the first quarterly dividend of $0.40 per share, a roughly 20% annualized payout ratio versus estimated 2026 pro forma standalone adjusted EPS, about $650 million of expected 2026 CapEx, and a likely step-up in CapEx next year to support growth projects including the new Arizona facility.

Analysts focused on how quickly supplier improvements can translate into better output and whether constraints could impede OEM customers or defense exports. Management said visibility into the most constrained suppliers has improved, that output should build quarter over quarter from Q4 2026 through 2027, and that the company is prioritizing OEM and domestic defense fulfillment while still seeing strong international defense demand. Questions also centered on margins and the 2027 outlook; management said the path is not linear, near-term investments will weigh on margins, and they expect 2027 to benefit from higher output, pricing resets, and ongoing supply-chain actions.